Pharmacokinetics of glycopyrrolate in children.
J Clin Anesth
; 6(3): 217-20, 1994.
Article
en En
| MEDLINE
| ID: mdl-8060629
ABSTRACT
STUDY OBJECTIVE:
To investigate the pharmacokinetics of glycopyrrolate in children.DESIGN:
Open study with three parallel groups.SETTING:
Pediatric surgery department at a university hospital. PATIENTS 26 healthy ASA physical status I children undergoing minor surgery.INTERVENTIONS:
Patients were assigned to 1 of 3 groups under 1 year of age (Group 1, n = 8), between 1 and 3 years of age (Group 2, n = 7), and over 3 years of age (Group 3, n = 11). Glycopyrrolate 5 micrograms/kg was given as a single intravenous (i.v.) injection before induction of general anesthesia. Blood samples (for determination of drug concentrations in plasma) were collected via venous cannula inserted into the contralateral antecubital vein. MEASUREMENTS AND MAINRESULTS:
ECG was observed continuously, blood pressure was measured with an automatic noninvasive device, and blood samples were taken just before and at 2, 4, 6, 10, 15, 30, 60, 120, 180, 240, 360, and 480 minutes after injection of glycopyrrolate. Glycopyrrolate concentrations in plasma were determined with a radioreceptor assay. The only significant difference in the pharmacokinetic parameters was the shortened elimination half-life in patients between 1 and 3 years of age. Glycopyrrolate 5 micrograms/kg i.v. did not cause any significant alterations in heart rate.CONCLUSIONS:
There were no significant changes in the distribution volume or clearance of glycopyrrolate in children of different ages. The shortened elimination half-life in children between 1 and 3 years of age is of minor clinical importance.
Buscar en Google
Colección:
01-internacional
Asunto principal:
Medicación Preanestésica
/
Glicopirrolato
Límite:
Child
/
Child, preschool
/
Humans
/
Infant
Idioma:
En
Revista:
J Clin Anesth
Asunto de la revista:
ANESTESIOLOGIA
Año:
1994
Tipo del documento:
Article
País de afiliación:
Finlandia